Reclassification of Heart Failure with Preserved Ejection Fraction Following Cardiac Sympathetic Nervous System

Toshihiko Goto1, Takafumi Nakayama2, Junki Yamamoto1

  • 1Department of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.

Tomography (Ann Arbor, Mich.)
|June 23, 2022
PubMed

Insights

A left ventricular ejection fraction (LVEF) of 58% better reclassifies heart failure patients based on cardiac sympathetic nervous system (SNS) activity and prognosis than the standard 50% threshold. This finding aids in understanding heart failure heterogeneity.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • Heart failure with preserved left ventricular ejection fraction (HFpEF) is complex and current LVEF cutoffs (50%) for classification are debated.
  • Cardiac sympathetic nervous system (SNS) activation is a known characteristic of heart failure.

Purpose of the Study:

  • To investigate if a left ventricular ejection fraction (LVEF) of 58% is a more suitable threshold than 50% for stratifying heart failure patients based on cardiac SNS activity and prognosis.
  • To compare cardiac SNS activity and all-cause mortality between heart failure patients with LVEF ≥ 58% and LVEF < 58%.

Main Methods:

  • Retrospective observational study of 63 heart failure patients.
  • 123I-metaiodobenzylguanidine (MIBG) scintigraphy was used to assess cardiac SNS activity.
  • Patients were analyzed using LVEF thresholds of 58% and 50%.

Main Results:

  • Patients with LVEF ≥ 58% showed significantly higher delayed heart/mediastinum (H/M) ratios (indicating lower SNS activity) compared to those with LVEF < 58% (2.1 vs. 1.7, p=0.004).
  • All-cause mortality was significantly lower in the LVEF ≥ 58% group (log-rank, p=0.04).
  • No significant differences in H/M ratio or mortality were observed between LVEF ≥ 50% and LVEF < 50% groups.

Conclusions:

  • An LVEF of 58% serves as a more appropriate cutoff for reclassifying heart failure patients according to cardiac SNS activity.
  • This revised threshold may improve prognostic stratification in heart failure patients.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
28
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
136
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23